-+ 0.00%
-+ 0.00%
-+ 0.00%

OCUGEN - CONDUCTING PHASE 3 LIMELIGHT TRIAL OF OCU400 WITH TOPLINE DATA EXPECTED IN Q1 2027

Reuters·11/10/2026 12:00:02

Please log in to view news